vivoVerse Inc. products

Our large-scale microfluidic chip for high-throughput screening of C. elegans disease models at high-content, is published in Nature Communications (DOI 10.1038/ncomms13023). The platform enables high-resolution imaging and analysis of ~4,000 C. elegans from 96 different populations in approximately 15 minutes.